Related Experiment Video
Updated: May 14, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Phenotypic Exploration in Patients with Heterozygous Variant in AFG3L2 Gene: A Case-Series and Literature Review
Sangeetha Yoganathan1, Laura Tochen2, Jacky Ganguly3
1Division of Neurology, Department of Pediatrics, The Hospital for Sick Children, Toronto, ON, Canada.
Background:
Variants in AFG3-Like Matrix AAA Peptidase, Subunit 2 (AFG3L2) gene are associated with diverse clinical phenotypes. Here, we describe phenotypic findings of two unrelated children with de novo heterozygous variant and one family with inherited heterozygous variant in AFG3L2 gene.
Cases:
A 3-year-old girl presented with global developmental delay, vision disturbances and frequent falls. She developed choreoathetosis, feeding difficulty and sleep disturbances from 3.5 years of age. Developmental regression, and optic atrophy were identified. An 11-year-old girl presented with left foot dystonia and tremulousness at 2 years of age which later progressed to developmental regression and generalized dystonia. Bilateral optic disc pallor was observed. In contrast, spinocerebellar ataxia 28 phenotype with variable expressivity was observed in adult patients with inherited heterozygous variant in AFG3L2 gene. Treatment with levodopa offered variable clinical benefits.
Conclusion:
Our report emphasizes phenotypic heterogeneity in children and adults with heterozygous variant in AFG3L2 gene.
More Related Videos
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Principles of Pharmacogenetics: Types of Genetic Variants
Incomplete Dominance
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Genetic Lingo
Pleiotropy

